These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1577671)

  • 1. Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase.
    Arora SK; Arjunan P
    J Antibiot (Tokyo); 1992 Mar; 45(3):428-31. PubMed ID: 1577671
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of structure and activity in ansamycins: structure, conformation, and interactions of antibiotic rifamycin S.
    Arora SK
    J Med Chem; 1985 Aug; 28(8):1099-102. PubMed ID: 4020831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
    Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
    Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of Saccharomyces cerevisiae RNA polymerase by rifamycin derivatives (rifamycins and yeast RNA polymerase).
    Di Mauro E; Mezzina M; Arcà M
    Arch Biochem Biophys; 1974 Oct; 164(2):765-8. PubMed ID: 4618080
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
    McMillian R; Medoff G; Schlessinger D; Kobayashi GS
    Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of rifamycins with mammalian nucleic acid polymerizing enzymes.
    Sethi VS; Okano P
    Biochim Biophys Acta; 1976 Dec; 454(2):230-47. PubMed ID: 63293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal DNA-dependent RNA polymerases. 4. Studies on inhibition by rifamycin derivatives.
    Meilhac M; Tysper Z; Chambon P
    Eur J Biochem; 1972 Jul; 28(2):291-300. PubMed ID: 4560736
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic desymmetrization of a meso polyol corresponding to the C(19)-C(27) segment of rifamycin S.
    Chênevert R; Rose YS
    J Org Chem; 2000 Mar; 65(6):1707-9. PubMed ID: 10750492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of T7 specific RNA polymerase. 3. Inhibition by derivatives of rifamycin SV.
    Chamberlin MJ; Ring J
    Biochem Biophys Res Commun; 1972 Nov; 49(4):1129-36. PubMed ID: 4641709
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the rifamycin dimers on the activities of nucleic acid polymerases from various sources. Relation between lipophily and toxicity.
    Talpaert-Borlé M; Campagnari F; Discenza G
    J Antibiot (Tokyo); 1975 Aug; 28(8):580-9. PubMed ID: 1158783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling of wild-type, D516V, and H526L Mycobacterium tuberculosis RNA polymerase and their molecular docking study with inhibitors.
    Josa D; da Cunha EF; Ramalho TC; Souza TC; Caetano MS
    J Biomol Struct Dyn; 2008 Feb; 25(4):373-6. PubMed ID: 18092831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit contacts of the rifamycin binding site of RNA polymerase (B. subtilis).
    Rice LS; Meares CF
    Biochem Biophys Res Commun; 1978 Jan; 80(1):26-32. PubMed ID: 414752
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
    Tsai MJ; Saunders GF
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2072-6. PubMed ID: 4516206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modifications of the aliphatic bridge of ansamycins. Synthesis and activity of 25-deacetoxy-25-epi-hydroxyrifamycin S.
    Brizzi V; Brufani M; Cellai L; Segre AL
    J Antibiot (Tokyo); 1983 May; 36(5):516-21. PubMed ID: 6874570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by derivatives of rifamycin of soluble ribonucleic acid polymerase from rat liver.
    Onishi T; Muramatsu M
    Biochem J; 1972 Aug; 128(5):1361-4. PubMed ID: 4643707
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.
    Stender W; Scheit KH
    Eur J Biochem; 1977 Jun; 76(2):591-600. PubMed ID: 330165
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery, properties, and biosynthesis of pseudouridimycin, an antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase.
    Maffioli SI; Sosio M; Ebright RH; Donadio S
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):335-343. PubMed ID: 30465105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.